Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery : study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)
- Author
- MEM van der Noordaa, FH van Duijnhoven, CE Loo, E van Werkhoven, Koen Van de Vijver (UGent) , T Wiersma, HAO Winter-Warnars, GS Sonke and MTFD Vrancken Peeters
- Organization
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 822.44 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8577165
- MLA
- van der Noordaa, MEM, et al. “Identifying Pathologic Complete Response of the Breast after Neoadjuvant Systemic Therapy with Ultrasound Guided Biopsy to Eventually Omit Surgery : Study Design and Feasibility of the MICRA Trial (Minimally Invasive Complete Response Assessment).” BREAST, vol. 40, 2018, pp. 76–81, doi:10.1016/j.breast.2018.04.015.
- APA
- van der Noordaa, M., van Duijnhoven, F., Loo, C., van Werkhoven, E., Van de Vijver, K., Wiersma, T., … Vrancken Peeters, M. (2018). Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery : study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment). BREAST, 40, 76–81. https://doi.org/10.1016/j.breast.2018.04.015
- Chicago author-date
- Noordaa, MEM van der, FH van Duijnhoven, CE Loo, E van Werkhoven, Koen Van de Vijver, T Wiersma, HAO Winter-Warnars, GS Sonke, and MTFD Vrancken Peeters. 2018. “Identifying Pathologic Complete Response of the Breast after Neoadjuvant Systemic Therapy with Ultrasound Guided Biopsy to Eventually Omit Surgery : Study Design and Feasibility of the MICRA Trial (Minimally Invasive Complete Response Assessment).” BREAST 40: 76–81. https://doi.org/10.1016/j.breast.2018.04.015.
- Chicago author-date (all authors)
- van der Noordaa, MEM, FH van Duijnhoven, CE Loo, E van Werkhoven, Koen Van de Vijver, T Wiersma, HAO Winter-Warnars, GS Sonke, and MTFD Vrancken Peeters. 2018. “Identifying Pathologic Complete Response of the Breast after Neoadjuvant Systemic Therapy with Ultrasound Guided Biopsy to Eventually Omit Surgery : Study Design and Feasibility of the MICRA Trial (Minimally Invasive Complete Response Assessment).” BREAST 40: 76–81. doi:10.1016/j.breast.2018.04.015.
- Vancouver
- 1.van der Noordaa M, van Duijnhoven F, Loo C, van Werkhoven E, Van de Vijver K, Wiersma T, et al. Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery : study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment). BREAST. 2018;40:76–81.
- IEEE
- [1]M. van der Noordaa et al., “Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery : study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment),” BREAST, vol. 40, pp. 76–81, 2018.
@article{8577165,
author = {{van der Noordaa, MEM and van Duijnhoven, FH and Loo, CE and van Werkhoven, E and Van de Vijver, Koen and Wiersma, T and Winter-Warnars, HAO and Sonke, GS and Vrancken Peeters, MTFD}},
issn = {{0960-9776}},
journal = {{BREAST}},
language = {{eng}},
location = {{Chicago, IL, USA}},
pages = {{76--81}},
title = {{Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery : study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)}},
url = {{http://doi.org/10.1016/j.breast.2018.04.015}},
volume = {{40}},
year = {{2018}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: